ABOUT THIS EVENT
BioNTech SE (Nasdaq: BNTX), a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious diseases, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, Professor Ugur Sahin, M.D., Co-Founder & CEO, rang the Opening Bell.